Krka, d. d. (WSE:KRK)

Market Cap	32.87B +42.9%
Revenue (ttm)	8.96B +7.2%
Net Income	1.60B -9.3%
EPS	51.44 -10.3%
Shares Out	n/a
PE Ratio	20.57
Forward PE	19.12
Dividend	35.03 (3.19%)
Ex-Dividend Date	Jul 22, 2025

Volume	14
Open	1,110.00
Previous Close	1,074.00
Day's Range	1,080.00 - 1,110.00
52-Week Range	748.00 - 1,180.00
Beta	0.42
Analysts	n/a
Price Target	n/a
Earnings Date	May 14, 2026

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, and other therapeutic areas. It also provides non-prescription products for cough, cold, cerebral, peripheral circulation, gastrointestinal tract, metabo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 11,667
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: KRK

Financial Performance

In 2025, Krka, d. d.'s revenue was 2.04 billion, an increase of 6.89% compared to the previous year's 1.91 billion. Earnings were 403.24 million, an increase of 12.96%.

Financial numbers in EUR